Patents Assigned to BONEGENE.co.,Ltd.
  • Publication number: 20200375919
    Abstract: The present disclosure relates to a bone graft material grafted with 4-hexylresorcinol affecting bone formation, the bone graft material which not only can rapidly promote bone formation by mixing hydrous ethanol having low concentration 4-hexylresorcinol dissolved therein and a base material for release control with distilled water or a salt-dissolved aqueous solution to obtain a mixed solution and precipitating a bone graft material into the mixed solution, thereby injecting 4-hexylresorcinol into the bone graft material, but also can have a consistent treatment effect by adjusting elution amount of 4-hexylresorcinol through the base material for release control, thereby allowing 4-hexylresorcinol to be slowly released during a treatment period.
    Type: Application
    Filed: May 27, 2020
    Publication date: December 3, 2020
    Applicants: MANTIZ LOGITECH CO., LTD., BONEGENE.co.,Ltd.
    Inventors: Dae Chul CHO, Je Yong CHOI, Seong Hwan KIM, Ki Young KIM